Brief: Galecto posts Q1 basic EPS USD -0.51
28/04/2023 13:08
Apr 28 (Reuters) - Galecto Q1 basic EPS USD -0.51. * Q1 cash & investments USD 57.2 million * Q1 net income USD -13 million
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing